COVID-19: before stopping specific infection prevention and control measures, be sure to exclude the diagnosis

Farfour, Éric; Ballester, Marie; Lecuru, Marion; Verrat, Anne; Imhaus, Etienne; Mellot, François; Karnycheff, F.; Vasse, Marc; Cerf, Charles; Lesprit, Philippe

doi:10.1016/j.jhin.2020.04.021

Cited by 6 publications

(8 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Using such a strategy could, therefore, encourage to stop infection prevention and control (IPC) measure before the RT-PCR result was obtained. Finally, generating a contrary effect to what expected and increasing the risk of transmission [12]. Therefore, when RT-PCR is not easily available, we emphasize IPC should be implemented in all suspected patients on the basis of epidemiological, clinical, or radiological findings.…”

mentioning

confidence: 95%

SARS-CoV-2 RT-PCR and Chest CT, two complementary approaches for COVID-19 diagnosis

et al. 2020

View full text Add to dashboard Cite

mentioning

confidence: 95%

SARS-CoV-2 RT-PCR and Chest CT, two complementary approaches for COVID-19 diagnosis

et al. 2020

View full text Add to dashboard Cite

“…contact and respiratory precautions) should be rigorously applied. 2 , 3 Furthermore, the hospitals were organized with specific departments dedicated to SARS-CoV-2-infected patients (COVID-19-departments). As this context implies upgraded IPC measures, the risk of hospital-transmission of other micro-organisms such as extremely drug-resistant micro-organisms (eXDR), i.e.…”

Section: Introductionmentioning

confidence: 99%

“…1 In order to limit the spread of SARS-CoV-2 to other patients and health care workers, infection prevention and control (IPC) measures (ie, contact and respiratory precautions) should be rigorously applied. 2,3 Furthermore, the hospitals were organized with specific departments dedicated to SARS-CoV-2infected patients (COVID-19-departments). As this context implies upgraded IPC measures, the risk of hospital-transmission of other micro-organisms such as extremely drug-resistant micro-organisms (eXDR), that is, carbapenemase-producing Enterobacterales (CPE) and vancomycin-resistant Enterococcus might be reduced in COVID-19departments.…”

Section: Introductionmentioning

confidence: 99%

Carbapenemase-producing Enterobacterales outbreak: Another dark side of COVID-19

Farfour

Lecuru

Dortet

et al. 2020

American Journal of Infection Control

View full text Add to dashboard Cite

In the hospital department dedicated to COVID-19-patient, infection prevention and control measures were upgraded. Therefore, the cross-transmission of other micro-organisms was thought unlikely to occur. However, we report an outbreak of NDM-5-producing E. coli in a 12-beds ICU dedicated to COVID-19 patients. This outbreak involved 6 patients of which 5 were asymptomatic carriers and 1 was infected. Several findings might have contributed to cross-transmission including the multiple-bedroom configuration of the department, uncomplete compliance for standard and contact precautions, overwork due to the burden of the disease, lack of training of staff for the care of ICU-patients, and misuse of gloves. Furthermore, as infection prevention and control measures were thought to be the applied, contact patients were not screened for eXDR carriage. Applying rigorously standard and contact precautions and performing screening in contact patients when indicated must be the rules in COVID-19 wards.

show abstract

“…The clinical presentation of COVID-19 is non-specific, so it needs a robust and accurate diagnosis. It has been suggested that before stopping the infection control measures, we have to be sure to exclude the diagnosis [97]. Prevention plays a vital role in treating and defeating the COVID-19 disaster.…”

Section: Discussionmentioning

confidence: 99%

COVID-19 pandemic crisis—a complete outline of SARS-CoV-2

et al. 2020

View full text Add to dashboard Cite

Background Coronavirus (SARS-CoV-2), the cause of COVID-19, a fatal disease emerged from Wuhan, a large city in the Chinese province of Hubei in December 2019. Main body of abstract The World Health Organization declared COVID-19 as a pandemic due to its spread to other countries inside and outside Asia. Initial confirmation of the pandemic shows patient exposure to the Huanan seafood market. Bats might be a significant host for the spread of coronaviruses via an unknown intermediate host. The human-to-human transfer has become a significant concern due to one of the significant reasons that is asymptomatic carriers or silent spreaders. No data is obtained regarding prophylactic treatment for COVID-19, although many clinical trials are underway. Conclusion The most effective weapon is prevention and precaution to avoid the spread of the pandemic. In this current review, we outline pathogenesis, diagnosis, treatment, ongoing clinical trials, prevention, and precautions. We have also highlighted the impact of pandemic worldwide and challenges that can help to overcome the fatal disease in the future.

show abstract

COVID-19: before stopping specific infection prevention and control measures, be sure to exclude the diagnosis

Cited by 6 publications

References 7 publications

SARS-CoV-2 RT-PCR and Chest CT, two complementary approaches for COVID-19 diagnosis

SARS-CoV-2 RT-PCR and Chest CT, two complementary approaches for COVID-19 diagnosis

Carbapenemase-producing Enterobacterales outbreak: Another dark side of COVID-19

COVID-19 pandemic crisis—a complete outline of SARS-CoV-2

Contact Info

Product

Resources

About